In Media Corporation (IMDC) 0.0024 $IMDC
Folio:'s Top Women In Media Luncheon Honors Trusted Media Brands
PRWeb - Thu Jun 09, 2:01PM CDT
During today's 2016 Folio: Top Women in Media Awards, two women from Trusted Media Brands, Inc., an iconic, multiplatform media company, were honored as part of Folio:'s 2016 class.
World Market for Prescription Dermatological Drugs, 2015 Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
M2 - Tue Sep 22, 4:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9h5tp4/world_market_for) has announced the addition of the "World Market for Prescription Dermatological Drugs, 9th Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)" report to their offering. The worldwide market for prescription dermatological drugs encompasses a wide variety of products that treat disorders of the skin as well as the effects of aging. It's a very dynamic time for the prescription dermatological drug industry. Consolidation, economic times, new technologies and genetic discoveries are among the trends that the industry is seeing. The field of dermatology is currently experiencing a busy and interesting period and, as a result, the range of therapeutic options available to physicians has expanded. The driving forces for this market include growth and aging of the worldwide population, new products and technologies, and focus on lifestyle treatments that improve the effects of aging and damage to the skin. Within the pharmaceutical industry as a whole, financial depression, consolidation and economic downturns have influenced the market. The worldwide market for prescription dermatology drugs includes products in the following categories: - Prescription Acne and Rosacea Drugs - Prescription Antiaging and Photodamage Drugs - Prescription Dermatitis and Seborrhea Drugs - Prescription Fungal Infection Drugs - Prescription Hair Loss and Hair Removal Drugs - Prescription Hyperpigmentation/Melasma Drugs - Prescription Psoriasis Drugs - Prescription Skin Cancer Drugs - Other Prescription Skin Disorder Drugs This report details the various categories of prescription dermatological drugs, describes the worldwide market for prescription dermatological drugs, and identifies major market factors that may help to shape the worldwide market for prescription dermatological drugs in the future. The following companies are profiled in this report: - Allergan Inc. - Allergan Inamed Corporation - Barrier Therapeutics, Inc - Bayer AG - PharmaDerm Pharmaceuticals, Inc - Bristol-Myers Squibb - Collagenex (now Galderma) Pharmaceuticals - Galderma S.A. - Genentech, Inc. - GlaxoSmithKline Plc - Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil) - Medicis Pharmaceutical Corporation - Merck & Company, Inc. - Mylan Pharmaceuticals, Inc, - Novartis Pharmaceuticals Corporation - Nycomed Inc. - Pfizer, Inc. - Q-Med AB - Roche Group (F. Hoffmann-La Roche Ltd.) - Schering (now Merck)-Plough Corporation - Sinclair Pharma Plc. - SkinMedica - Stiefel Laboratories, Inc. - Valeant Pharmaceuticals, Inc. Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Issues And Trends Chapter Four: Prescription Antiacne And Rosacea Drugs Chapter Five: Prescription Antiaging And Photodamage Drugs Chapter Six: Prescription Dermatitis And Seborrhea Drugs Chapter Seven: Prescription Antifungal Drugs Chapter Eight: Prescription Hair Loss And Hair Removal Drugs Chapter Nine: Prescription Hyperpigmentation/Melasma And Depigmenting Drugs Chapter Ten: Prescription Psoriasis Drugs Chapter Eleven: Prescription Skin Cancer Drugs Chapter Twelve: Miscellaneous Skin Disorder Drugs Chapter Thirteen: World Market Summary Chapter Fourteen: Corporate Profiles For more information visit http://www.researchandmarkets.com/research/9h...market_for
AGN: 235.05 (-2.24), JNJ: 115.48 (-1.16), PFE: 34.22 (-0.53), MRK: 55.89 (-1.61), GSK: 40.33 (-0.24), BMY: 70.67 (-1.06), NVS: 77.91 (+1.02)
Brickell Biotech Announces Appointment of Industry Veteran Patricia Walker, MD, PhD as President and Chief Scientific Officer
BusinessWire - Wed Jul 08, 7:00AM CDT
Brickell Biotech, Inc. ("Brickell"
, a clinical-stage pharmaceutical company focused on the development of differentiated, innovative therapeutics to satisfy current unmet medical needs in the global dermatology markets, today announced that Patricia Walker, MD, PhD, has joined as President and Chief Scientific Officer. Dr. Walker, a board-certified dermatologist specializing in medical and aesthetic dermatology, most recently served as the Chief Medical Officer for Kythera Biopharmaceuticals, Inc.
In Media Corporation, (IMDC) to acquire and merge with Hip Appeal, Inc.
PR Newswire - Tue Jun 30, 6:19PM CDT
Following a letter of intent signed on October 28, 2014, the Board of In Media Corporation (IMDC) today announced that they had committed to a definitive agreement to acquire and merge with Hip Appeal Inc. for a total consideration of 67,300,205 shares of Common Stock. Howard Hayes, CEO of Hip Appeal was confirmed as CEO and Chairman of the Board of IMDC. IMDC will now be producing and selling women's leisure clothing under the Hip Appeal brand for sale into retail, on-line, including corporate identity branding, licensing and wholesale vendor trade shows events. The Company intends to extend its channels of distribution globally and increase product lines in the near future and, to reflect the new business focus, it will be changing its name from In Media Corporation to Hip Appeal Inc. and applying to FINRA for a new ticker symbol.
Folio: Announces Annual List of Top Women in Media; Honorees To Be Celebrated At June 8, 2015 Luncheon
PRWeb - Thu Apr 09, 9:05AM CDT
Folio: is excited to announce its 2015 list of Top Women in Media. This annual program celebrates the creativity, innovation, and accomplishments of women in the magazine media industry--despite the daily hurdles they may face. These women have fearlessly moved their brands, teams, and companies in new directions, propelling this industry into the future.
Teenage Celebrity Radio Host Pavlina Osta Wins Second Consecutive Gracie Award
PRWeb - Tue Mar 17, 7:09AM CDT
Teen radio host and journalist, Pavlina Osta won her second consecutive Gracie Award in the Outstanding Host - News/Non-Fiction category by the Alliance for Women In Media Foundation (AWMF). Last year Pavlina won a Gracie Award in the Outstanding Anchor category. Pavlina joins the ranks of Hoda Kotb who also won a Gracie Award for Outstanding Host in addition to other leaders including Cicely Tyson, Julia Roberts, Robin Roberts, and Maggie Gyllenhaal among others.
In Media Corporation Announces Letter of Intent to Acquire Hip Appeal
Marketwired - Thu Nov 20, 8:03AM CST
In Media Corporation (OTCQB: IMDC) today announced that it has entered into a non-binding letter of intent to acquire all of the issued and outstanding common shares of Hip Appeal, an emerging apparel company that caters to the fashion conscious, active, on-the-go female.
Folio:'s Top Women In Media Luncheon Honors Trusted Media Brands
PRWeb - Thu Jun 09, 2:01PM CDT
During today's 2016 Folio: Top Women in Media Awards, two women from Trusted Media Brands, Inc., an iconic, multiplatform media company, were honored as part of Folio:'s 2016 class.
World Market for Prescription Dermatological Drugs, 2015 Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
M2 - Tue Sep 22, 4:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9h5tp4/world_market_for) has announced the addition of the "World Market for Prescription Dermatological Drugs, 9th Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)" report to their offering. The worldwide market for prescription dermatological drugs encompasses a wide variety of products that treat disorders of the skin as well as the effects of aging. It's a very dynamic time for the prescription dermatological drug industry. Consolidation, economic times, new technologies and genetic discoveries are among the trends that the industry is seeing. The field of dermatology is currently experiencing a busy and interesting period and, as a result, the range of therapeutic options available to physicians has expanded. The driving forces for this market include growth and aging of the worldwide population, new products and technologies, and focus on lifestyle treatments that improve the effects of aging and damage to the skin. Within the pharmaceutical industry as a whole, financial depression, consolidation and economic downturns have influenced the market. The worldwide market for prescription dermatology drugs includes products in the following categories: - Prescription Acne and Rosacea Drugs - Prescription Antiaging and Photodamage Drugs - Prescription Dermatitis and Seborrhea Drugs - Prescription Fungal Infection Drugs - Prescription Hair Loss and Hair Removal Drugs - Prescription Hyperpigmentation/Melasma Drugs - Prescription Psoriasis Drugs - Prescription Skin Cancer Drugs - Other Prescription Skin Disorder Drugs This report details the various categories of prescription dermatological drugs, describes the worldwide market for prescription dermatological drugs, and identifies major market factors that may help to shape the worldwide market for prescription dermatological drugs in the future. The following companies are profiled in this report: - Allergan Inc. - Allergan Inamed Corporation - Barrier Therapeutics, Inc - Bayer AG - PharmaDerm Pharmaceuticals, Inc - Bristol-Myers Squibb - Collagenex (now Galderma) Pharmaceuticals - Galderma S.A. - Genentech, Inc. - GlaxoSmithKline Plc - Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil) - Medicis Pharmaceutical Corporation - Merck & Company, Inc. - Mylan Pharmaceuticals, Inc, - Novartis Pharmaceuticals Corporation - Nycomed Inc. - Pfizer, Inc. - Q-Med AB - Roche Group (F. Hoffmann-La Roche Ltd.) - Schering (now Merck)-Plough Corporation - Sinclair Pharma Plc. - SkinMedica - Stiefel Laboratories, Inc. - Valeant Pharmaceuticals, Inc. Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Issues And Trends Chapter Four: Prescription Antiacne And Rosacea Drugs Chapter Five: Prescription Antiaging And Photodamage Drugs Chapter Six: Prescription Dermatitis And Seborrhea Drugs Chapter Seven: Prescription Antifungal Drugs Chapter Eight: Prescription Hair Loss And Hair Removal Drugs Chapter Nine: Prescription Hyperpigmentation/Melasma And Depigmenting Drugs Chapter Ten: Prescription Psoriasis Drugs Chapter Eleven: Prescription Skin Cancer Drugs Chapter Twelve: Miscellaneous Skin Disorder Drugs Chapter Thirteen: World Market Summary Chapter Fourteen: Corporate Profiles For more information visit http://www.researchandmarkets.com/research/9h...market_for
AGN: 235.05 (-2.24), JNJ: 115.48 (-1.16), PFE: 34.22 (-0.53), MRK: 55.89 (-1.61), GSK: 40.33 (-0.24), BMY: 70.67 (-1.06), NVS: 77.91 (+1.02)
Brickell Biotech Announces Appointment of Industry Veteran Patricia Walker, MD, PhD as President and Chief Scientific Officer
BusinessWire - Wed Jul 08, 7:00AM CDT
Brickell Biotech, Inc. ("Brickell"
, a clinical-stage pharmaceutical company focused on the development of differentiated, innovative therapeutics to satisfy current unmet medical needs in the global dermatology markets, today announced that Patricia Walker, MD, PhD, has joined as President and Chief Scientific Officer. Dr. Walker, a board-certified dermatologist specializing in medical and aesthetic dermatology, most recently served as the Chief Medical Officer for Kythera Biopharmaceuticals, Inc. In Media Corporation, (IMDC) to acquire and merge with Hip Appeal, Inc.
PR Newswire - Tue Jun 30, 6:19PM CDT
Following a letter of intent signed on October 28, 2014, the Board of In Media Corporation (IMDC) today announced that they had committed to a definitive agreement to acquire and merge with Hip Appeal Inc. for a total consideration of 67,300,205 shares of Common Stock. Howard Hayes, CEO of Hip Appeal was confirmed as CEO and Chairman of the Board of IMDC. IMDC will now be producing and selling women's leisure clothing under the Hip Appeal brand for sale into retail, on-line, including corporate identity branding, licensing and wholesale vendor trade shows events. The Company intends to extend its channels of distribution globally and increase product lines in the near future and, to reflect the new business focus, it will be changing its name from In Media Corporation to Hip Appeal Inc. and applying to FINRA for a new ticker symbol.
Folio: Announces Annual List of Top Women in Media; Honorees To Be Celebrated At June 8, 2015 Luncheon
PRWeb - Thu Apr 09, 9:05AM CDT
Folio: is excited to announce its 2015 list of Top Women in Media. This annual program celebrates the creativity, innovation, and accomplishments of women in the magazine media industry--despite the daily hurdles they may face. These women have fearlessly moved their brands, teams, and companies in new directions, propelling this industry into the future.
Teenage Celebrity Radio Host Pavlina Osta Wins Second Consecutive Gracie Award
PRWeb - Tue Mar 17, 7:09AM CDT
Teen radio host and journalist, Pavlina Osta won her second consecutive Gracie Award in the Outstanding Host - News/Non-Fiction category by the Alliance for Women In Media Foundation (AWMF). Last year Pavlina won a Gracie Award in the Outstanding Anchor category. Pavlina joins the ranks of Hoda Kotb who also won a Gracie Award for Outstanding Host in addition to other leaders including Cicely Tyson, Julia Roberts, Robin Roberts, and Maggie Gyllenhaal among others.
In Media Corporation Announces Letter of Intent to Acquire Hip Appeal
Marketwired - Thu Nov 20, 8:03AM CST
In Media Corporation (OTCQB: IMDC) today announced that it has entered into a non-binding letter of intent to acquire all of the issued and outstanding common shares of Hip Appeal, an emerging apparel company that caters to the fashion conscious, active, on-the-go female.
